|
|
News Breaks | | | | January 6, 2013 | | 11:28 EDT |  | AMAG | AMAG sees Q4 revenue $21.1M-$21.5M, consensus $29.94M
For Q412, AMAG expects total revenues of between $21.1M- $21.5M, including between $14.4-$14.8M of net U.S. Feraheme product revenues. The approximate 14% growth in U.S. net product revenues, compared to the fourth quarter of 2011, was driven by increased volume and an improving net effective price per gram for Feraheme. | |
|
News For AMAG From The Last 14 Days Check below for free stories on AMAG the last two weeks. |
|
|
| May 15, 2013 | | 09:53 EDT |  | AMAG | AMAG Pharmaceuticals management to meet with Leerink
 Subscribe for More Information | |
|
|
|
|
|
|
